Impedance based RTCA explained

BioSPX, specialists in real time cell analysis in Belgium, Luxembourg and the Netherlands

Intro

Impedance-based real-time cell analysis monitors changes in the electrical response of cells interacting with electrodes. In Agilent xCELLigence systems, integrated microelectrodes provide a label-free, kinetic readout sensitive to cell attachment, morphology and cell number. Measurements follow the same culture over time, helping researchers identify response onset and duration. [1,2]

How cellular impedance is measured

A small alternating electrical signal is applied across electrodes in specialised culture plates. Cells attaching and spreading over the electrode surface change the measured impedance. xCELLigence software reports a derived, dimensionless parameter called Cell Index. Its value reflects the integrated effects of cell coverage, attachment and morphology under the assay conditions. It is not a direct electrical count of individual cells. [2]

Applications for kinetic cell assays

RTCA is used to study proliferation, adhesion, compound responses and cell-mediated cytotoxicity. Repeated measurements can distinguish rapid responses from delayed effects and reveal transient changes that endpoint assays may miss. Biological interpretation still depends on the experimental model. An early attachment response and a later proliferation response can influence different parts of the same trace. [1,3]

Interpreting changes in Cell Index

A falling Cell Index can reflect cell detachment, altered spreading, loss of viability or a combination of effects. An increase can also arise from changes in morphology or attachment. Published experiments demonstrate that cells at the same number can produce different impedance signals when their morphology changes. [3] Use imaging, viability markers or other suitable endpoints to establish the mechanism relevant to the experiment. Normalised Cell Index expresses change relative to a selected time point; it does not remove every biological or technical confounder.

The impedance of electron flow caused by adherent cells is reported using a unitless parameter called Cell Index (CI), where CI = (impedance at time point n – impedance in the absence of cells)/nominal impedance value. Figure 3 provides a generic example of a real-time impedance trace throughout the course of setting up and running an apoptosis experiment. For the first few hours after cells have been added to a well there is a rapid increase in impedance. This is caused by cells falling out of suspension, depositing onto the electrodes, and forming focal adhesions. If the initial number of added cells is low and there is empty space on the well bottom cells will proliferate, causing a gradual yet steady increase in CI. When cells reach confluence the CI value plateaus, reflecting the fact that the electrode surface area that is accessible to bulk media is no longer changing. The addition of an apoptosis inducer at this point causes a decrease in CI back down to zero. This is the result of cells rounding and then detaching from the well bottom. While this generic example involves drug addition when cells are confluent, impedance-based assays are extremely flexible and can also evaluate the rate and extent of initial cell adhesion to the electrodes, or the rate and extent of cell proliferation.

Fig: Generic real-time impedance trace for setting up and running an apoptosis assay. Each phase of the impedance trace, and the cellular behavior it arises from, is explained in the text.

Relevant instruments

BioSPX lists S16, SP, MP, DP, HT and eSight platforms. RTCA DP supports migration and invasion measurements using dedicated CIM-Plates. RTCA eSight combines impedance with fluorescence and brightfield imaging, which can provide complementary visual information. These capabilities are model-specific. 

FAQ

BioSPX helps researchers in the Benelux with all their questions.

 

Impedance can reveal changes consistent with cytotoxicity, but a trace alone does not identify the underlying mechanism. Use a validated assay design and confirmatory endpoints where needed.

Only through an assay-specific calibration under conditions where attachment and morphology remain sufficiently consistent. A universal conversion is inappropriate.